Gilead Sciences, Inc. ( GILD ) will begin trading ex-dividend on December 14, 2015. A cash dividend payment of $0.43 per share is scheduled to be paid on December 30, 2015. Shareholders who purchased GILD prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that GILD has paid the same dividend. At the current stock price of $102.62, the dividend yield is 1.68%.
The previous trading day's last sale of GILD was $102.62, representing a -16.82% decrease from the 52 week high of $123.37 and a 19.39% increase over the 52 week low of $85.95.
GILD is a part of the Health Care sector, which includes companies such as Amgen Inc. ( AMGN ) and Biogen Inc. ( BIIB ). GILD's current earnings per share, an indicator of a company's profitability, is $10.92. Zacks Investment Research reports GILD's forecasted earnings growth in 2015 as 51.35%, compared to an industry average of 10.2%.
Interested in gaining exposure to GILD through an Exchange Traded Fund [ETF]?
The following ETF(s) have GILD as a top-10 holding:
- iShares Nasdaq Biotechnology Index Fund ( IBB )
- SPDR Select Sector Fund - Health Care ( XLV )
- iShares U.S. Healthcare ETF ( IYH )
- PowerShares Dynamic Pharmaceuticals ( PJP )
- Market Vectors Biotech ETF ( BBH ).
The top-performing ETF of this group is XLV with an decrease of -7.19% over the last 100 days. IBB has the highest percent weighting of GILD at 7.03%.